HEADER TRANSFERASE 08-AUG-06 2HZ0 TITLE ABL KINASE DOMAIN IN COMPLEX WITH NVP-AEG082 COMPND MOL_ID: 1; COMPND 2 MOLECULE: PROTO-ONCOGENE TYROSINE-PROTEIN KINASE ABL1; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: P150, C-ABL, ABELSON MURINE LEUKEMIA VIRAL ONCOGENE HOMOLOG COMPND 5 1; COMPND 6 EC: 2.7.10.2; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: ABL1; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_COMMON: FALL ARMYWORM; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 7108 KEYWDS TYROSINE KINASE, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR S.W.COWAN-JACOB,G.FENDRICH,J.LIEBETANZ,D.FABBRO,P.MANLEY REVDAT 4 30-AUG-23 2HZ0 1 REMARK REVDAT 3 18-OCT-17 2HZ0 1 REMARK REVDAT 2 24-FEB-09 2HZ0 1 VERSN REVDAT 1 16-JAN-07 2HZ0 0 JRNL AUTH S.W.COWAN-JACOB,G.FENDRICH,A.FLOERSHEIMER,P.FURET, JRNL AUTH 2 J.LIEBETANZ,G.RUMMEL,P.RHEINBERGER,M.CENTELEGHE,D.FABBRO, JRNL AUTH 3 P.W.MANLEY JRNL TITL STRUCTURAL BIOLOGY CONTRIBUTIONS TO THE DISCOVERY OF DRUGS JRNL TITL 2 TO TREAT CHRONIC MYELOGENOUS LEUKAEMIA. JRNL REF ACTA CRYSTALLOGR.,SECT.D V. 63 80 2007 JRNL REFN ISSN 0907-4449 JRNL PMID 17164530 JRNL DOI 10.1107/S0907444906047287 REMARK 2 REMARK 2 RESOLUTION. 2.10 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER-TNT REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SMART,VONRHEIN,WOMACK, REMARK 3 : MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.10 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 25.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : NULL REMARK 3 NUMBER OF REFLECTIONS : 35473 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : NULL REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : NULL REMARK 3 R VALUE (WORKING SET) : 0.195 REMARK 3 FREE R VALUE : 0.256 REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : 1778 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 2.10 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 2.18 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : NULL REMARK 3 BIN R VALUE (WORKING + TEST SET) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : 0.2000 REMARK 3 BIN FREE R VALUE : 0.2800 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : 160 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4091 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 62 REMARK 3 SOLVENT ATOMS : 387 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 31.11 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : NULL REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : NULL REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : NULL REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : NULL REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : NULL REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : NULL REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : NULL ; NULL ; NULL REMARK 3 BOND ANGLES : NULL ; NULL ; NULL REMARK 3 TORSION ANGLES : NULL ; NULL ; NULL REMARK 3 TRIGONAL CARBON PLANES : NULL ; NULL ; NULL REMARK 3 GENERAL PLANES : NULL ; NULL ; NULL REMARK 3 ISOTROPIC THERMAL FACTORS : NULL ; NULL ; NULL REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : NULL ; NULL ; NULL REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : NULL ; NULL ; NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.025 REMARK 3 BOND ANGLES (DEGREES) : 1.57 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : NULL REMARK 3 OTHER TORSION ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2HZ0 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 09-AUG-06. REMARK 100 THE DEPOSITION ID IS D_1000038929. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 28-MAR-01 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : BM1A REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.8000 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : MAR SCANNER 345 MM PLATE REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 35534 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.100 REMARK 200 RESOLUTION RANGE LOW (A) : 25.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.8 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : 0.08700 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 6.6000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.10 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.18 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.9 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.26700 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: 1FPU REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 47.60 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.35 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 28 % PEG 4000, 0.1 M TRIS.HCL PH 8.0, REMARK 280 0.2 M NAACETATE, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 17.01000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 69.79500 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 61.98000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 69.79500 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 17.01000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 61.98000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 VAL A 228 REMARK 465 SER A 229 REMARK 465 PRO A 230 REMARK 465 ASN A 231 REMARK 465 TYR A 232 REMARK 465 GLY B 249 REMARK 465 GLY B 250 REMARK 465 GLY B 251 REMARK 465 GLN B 252 REMARK 465 TYR B 253 REMARK 465 GLY B 254 REMARK 465 LYS B 274 REMARK 465 GLU B 275 REMARK 465 ASP B 276 REMARK 465 THR B 277 REMARK 465 SER B 385 REMARK 465 ARG B 386 REMARK 465 LEU B 387 REMARK 465 MET B 388 REMARK 465 THR B 389 REMARK 465 GLY B 390 REMARK 465 ASP B 391 REMARK 465 THR B 392 REMARK 465 TYR B 393 REMARK 465 THR B 394 REMARK 465 ALA B 395 REMARK 465 HIS B 396 REMARK 465 ALA B 397 REMARK 465 GLY B 398 REMARK 465 ALA B 399 REMARK 465 LYS B 400 REMARK 465 PHE B 401 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 234 NZ REMARK 470 GLU A 238 CD OE1 OE2 REMARK 470 ARG A 239 NE CZ NH1 NH2 REMARK 470 LYS A 247 NZ REMARK 470 LYS A 262 NZ REMARK 470 LYS A 263 CD CE NZ REMARK 470 LYS A 274 CE NZ REMARK 470 GLU A 275 CD OE1 OE2 REMARK 470 GLU A 281 OE1 OE2 REMARK 470 ARG A 307 CZ NH1 NH2 REMARK 470 GLU A 308 CD OE1 OE2 REMARK 470 LYS A 400 NZ REMARK 470 GLU A 462 CD OE1 OE2 REMARK 470 GLU A 466 CD OE1 OE2 REMARK 470 LYS A 467 NZ REMARK 470 GLN A 491 CD OE1 NE2 REMARK 470 PHE A 497 C O REMARK 470 LYS B 247 CE NZ REMARK 470 LEU B 248 C O REMARK 470 GLU B 255 OE1 OE2 REMARK 470 LYS B 263 NZ REMARK 470 GLU B 279 CD OE1 OE2 REMARK 470 GLU B 281 CG CD OE1 OE2 REMARK 470 GLU B 282 CD OE1 OE2 REMARK 470 ARG B 332 CZ NH1 NH2 REMARK 470 GLN B 333 OE1 REMARK 470 ARG B 362 CZ NH1 NH2 REMARK 470 LEU B 384 C O REMARK 470 GLU B 462 OE1 REMARK 470 GLU B 466 OE2 REMARK 470 LYS B 467 NZ REMARK 470 GLN B 491 CD OE1 NE2 REMARK 470 PHE B 497 C REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 MET A 318 SD MET A 318 CE -0.385 REMARK 500 VAL A 422 CB VAL A 422 CG1 0.159 REMARK 500 GLU A 431 CB GLU A 431 CG 0.124 REMARK 500 TYR A 435 CE2 TYR A 435 CD2 0.117 REMARK 500 MET B 318 SD MET B 318 CE -0.413 REMARK 500 VAL B 339 CB VAL B 339 CG2 0.135 REMARK 500 ARG B 367 CG ARG B 367 CD 0.192 REMARK 500 ILE B 432 CB ILE B 432 CG2 0.229 REMARK 500 TYR B 435 CD1 TYR B 435 CE1 0.100 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ASP A 241 N - CA - C ANGL. DEV. = -19.4 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LYS A 234 -55.84 121.25 REMARK 500 THR A 240 25.83 82.66 REMARK 500 LYS A 245 -153.17 -108.83 REMARK 500 LYS A 262 -61.98 -11.10 REMARK 500 SER A 265 3.46 53.91 REMARK 500 ASP A 276 51.25 -108.88 REMARK 500 ARG A 362 -13.13 79.36 REMARK 500 LYS B 245 -120.72 -103.07 REMARK 500 ARG B 362 -10.24 87.26 REMARK 500 ASP B 363 53.27 -152.05 REMARK 500 MET B 496 31.41 38.32 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: PLANAR GROUPS REMARK 500 REMARK 500 PLANAR GROUPS IN THE FOLLOWING RESIDUES HAVE A TOTAL REMARK 500 RMS DISTANCE OF ALL ATOMS FROM THE BEST-FIT PLANE REMARK 500 BY MORE THAN AN EXPECTED VALUE OF 6*RMSD, WITH AN REMARK 500 RMSD 0.02 ANGSTROMS, OR AT LEAST ONE ATOM HAS REMARK 500 AN RMSD GREATER THAN THIS VALUE REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 M RES CSSEQI RMS TYPE REMARK 500 GLU B 409 0.07 SIDE CHAIN REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GIN A 600 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GIN B 600 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2HYY RELATED DB: PDB DBREF 2HZ0 A 228 497 UNP P00519 ABL1_HUMAN 228 497 DBREF 2HZ0 B 228 497 UNP P00519 ABL1_HUMAN 228 497 SEQRES 1 A 270 VAL SER PRO ASN TYR ASP LYS TRP GLU MET GLU ARG THR SEQRES 2 A 270 ASP ILE THR MET LYS HIS LYS LEU GLY GLY GLY GLN TYR SEQRES 3 A 270 GLY GLU VAL TYR GLU GLY VAL TRP LYS LYS TYR SER LEU SEQRES 4 A 270 THR VAL ALA VAL LYS THR LEU LYS GLU ASP THR MET GLU SEQRES 5 A 270 VAL GLU GLU PHE LEU LYS GLU ALA ALA VAL MET LYS GLU SEQRES 6 A 270 ILE LYS HIS PRO ASN LEU VAL GLN LEU LEU GLY VAL CYS SEQRES 7 A 270 THR ARG GLU PRO PRO PHE TYR ILE ILE THR GLU PHE MET SEQRES 8 A 270 THR TYR GLY ASN LEU LEU ASP TYR LEU ARG GLU CYS ASN SEQRES 9 A 270 ARG GLN GLU VAL ASN ALA VAL VAL LEU LEU TYR MET ALA SEQRES 10 A 270 THR GLN ILE SER SER ALA MET GLU TYR LEU GLU LYS LYS SEQRES 11 A 270 ASN PHE ILE HIS ARG ASP LEU ALA ALA ARG ASN CYS LEU SEQRES 12 A 270 VAL GLY GLU ASN HIS LEU VAL LYS VAL ALA ASP PHE GLY SEQRES 13 A 270 LEU SER ARG LEU MET THR GLY ASP THR TYR THR ALA HIS SEQRES 14 A 270 ALA GLY ALA LYS PHE PRO ILE LYS TRP THR ALA PRO GLU SEQRES 15 A 270 SER LEU ALA TYR ASN LYS PHE SER ILE LYS SER ASP VAL SEQRES 16 A 270 TRP ALA PHE GLY VAL LEU LEU TRP GLU ILE ALA THR TYR SEQRES 17 A 270 GLY MET SER PRO TYR PRO GLY ILE ASP LEU SER GLN VAL SEQRES 18 A 270 TYR GLU LEU LEU GLU LYS ASP TYR ARG MET GLU ARG PRO SEQRES 19 A 270 GLU GLY CYS PRO GLU LYS VAL TYR GLU LEU MET ARG ALA SEQRES 20 A 270 CYS TRP GLN TRP ASN PRO SER ASP ARG PRO SER PHE ALA SEQRES 21 A 270 GLU ILE HIS GLN ALA PHE GLU THR MET PHE SEQRES 1 B 270 VAL SER PRO ASN TYR ASP LYS TRP GLU MET GLU ARG THR SEQRES 2 B 270 ASP ILE THR MET LYS HIS LYS LEU GLY GLY GLY GLN TYR SEQRES 3 B 270 GLY GLU VAL TYR GLU GLY VAL TRP LYS LYS TYR SER LEU SEQRES 4 B 270 THR VAL ALA VAL LYS THR LEU LYS GLU ASP THR MET GLU SEQRES 5 B 270 VAL GLU GLU PHE LEU LYS GLU ALA ALA VAL MET LYS GLU SEQRES 6 B 270 ILE LYS HIS PRO ASN LEU VAL GLN LEU LEU GLY VAL CYS SEQRES 7 B 270 THR ARG GLU PRO PRO PHE TYR ILE ILE THR GLU PHE MET SEQRES 8 B 270 THR TYR GLY ASN LEU LEU ASP TYR LEU ARG GLU CYS ASN SEQRES 9 B 270 ARG GLN GLU VAL ASN ALA VAL VAL LEU LEU TYR MET ALA SEQRES 10 B 270 THR GLN ILE SER SER ALA MET GLU TYR LEU GLU LYS LYS SEQRES 11 B 270 ASN PHE ILE HIS ARG ASP LEU ALA ALA ARG ASN CYS LEU SEQRES 12 B 270 VAL GLY GLU ASN HIS LEU VAL LYS VAL ALA ASP PHE GLY SEQRES 13 B 270 LEU SER ARG LEU MET THR GLY ASP THR TYR THR ALA HIS SEQRES 14 B 270 ALA GLY ALA LYS PHE PRO ILE LYS TRP THR ALA PRO GLU SEQRES 15 B 270 SER LEU ALA TYR ASN LYS PHE SER ILE LYS SER ASP VAL SEQRES 16 B 270 TRP ALA PHE GLY VAL LEU LEU TRP GLU ILE ALA THR TYR SEQRES 17 B 270 GLY MET SER PRO TYR PRO GLY ILE ASP LEU SER GLN VAL SEQRES 18 B 270 TYR GLU LEU LEU GLU LYS ASP TYR ARG MET GLU ARG PRO SEQRES 19 B 270 GLU GLY CYS PRO GLU LYS VAL TYR GLU LEU MET ARG ALA SEQRES 20 B 270 CYS TRP GLN TRP ASN PRO SER ASP ARG PRO SER PHE ALA SEQRES 21 B 270 GLU ILE HIS GLN ALA PHE GLU THR MET PHE HET GIN A 600 31 HET GIN B 600 31 HETNAM GIN 2-{[(6-OXO-1,6-DIHYDROPYRIDIN-3-YL)METHYL]AMINO}-N-[4- HETNAM 2 GIN PROPYL-3-(TRIFLUOROMETHYL)PHENYL]BENZAMIDE FORMUL 3 GIN 2(C23 H22 F3 N3 O2) FORMUL 5 HOH *387(H2 O) HELIX 1 1 LYS A 262 SER A 265 5 4 HELIX 2 2 GLU A 279 LYS A 291 1 13 HELIX 3 3 LEU A 323 CYS A 330 1 8 HELIX 4 4 ASN A 336 ASN A 358 1 23 HELIX 5 5 ALA A 365 ARG A 367 5 3 HELIX 6 6 GLU A 373 HIS A 375 5 3 HELIX 7 7 ALA A 407 ASN A 414 1 8 HELIX 8 8 SER A 417 THR A 434 1 18 HELIX 9 9 ASP A 444 SER A 446 5 3 HELIX 10 10 GLN A 447 LYS A 454 1 8 HELIX 11 11 PRO A 465 TRP A 476 1 12 HELIX 12 12 ASN A 479 ARG A 483 5 5 HELIX 13 13 SER A 485 THR A 495 1 11 HELIX 14 14 GLU B 238 THR B 240 5 3 HELIX 15 15 LYS B 263 SER B 265 5 3 HELIX 16 16 GLU B 279 LYS B 291 1 13 HELIX 17 17 ASN B 322 CYS B 330 1 9 HELIX 18 18 ASN B 336 LYS B 357 1 22 HELIX 19 19 ALA B 365 ARG B 367 5 3 HELIX 20 20 GLU B 373 HIS B 375 5 3 HELIX 21 21 PRO B 402 THR B 406 5 5 HELIX 22 22 ALA B 407 ASN B 414 1 8 HELIX 23 23 SER B 417 THR B 434 1 18 HELIX 24 24 ASP B 444 SER B 446 5 3 HELIX 25 25 GLN B 447 LYS B 454 1 8 HELIX 26 26 PRO B 465 TRP B 476 1 12 HELIX 27 27 ASN B 479 ARG B 483 5 5 HELIX 28 28 SER B 485 THR B 495 1 11 SHEET 1 A 5 THR A 243 GLY A 250 0 SHEET 2 A 5 GLU A 255 TRP A 261 -1 O VAL A 256 N GLY A 249 SHEET 3 A 5 LEU A 266 THR A 272 -1 O VAL A 268 N GLY A 259 SHEET 4 A 5 TYR A 312 GLU A 316 -1 O THR A 315 N ALA A 269 SHEET 5 A 5 LEU A 301 CYS A 305 -1 N LEU A 302 O ILE A 314 SHEET 1 B 3 GLY A 321 ASN A 322 0 SHEET 2 B 3 CYS A 369 VAL A 371 -1 O VAL A 371 N GLY A 321 SHEET 3 B 3 VAL A 377 VAL A 379 -1 O LYS A 378 N LEU A 370 SHEET 1 C 5 ILE B 242 LYS B 247 0 SHEET 2 C 5 VAL B 256 TRP B 261 -1 O GLU B 258 N HIS B 246 SHEET 3 C 5 LEU B 266 LEU B 273 -1 O LEU B 266 N TRP B 261 SHEET 4 C 5 PHE B 311 GLU B 316 -1 O ILE B 313 N LYS B 271 SHEET 5 C 5 LEU B 301 CYS B 305 -1 N GLY B 303 O ILE B 314 SHEET 1 D 2 CYS B 369 VAL B 371 0 SHEET 2 D 2 VAL B 377 VAL B 379 -1 O LYS B 378 N LEU B 370 CISPEP 1 PRO A 309 PRO A 310 0 -3.92 CISPEP 2 PRO B 309 PRO B 310 0 -3.15 SITE 1 AC1 20 ALA A 269 LYS A 271 GLU A 286 MET A 290 SITE 2 AC1 20 ILE A 293 LEU A 298 VAL A 299 ILE A 313 SITE 3 AC1 20 THR A 315 GLU A 316 PHE A 317 MET A 318 SITE 4 AC1 20 HIS A 361 LEU A 370 VAL A 379 ALA A 380 SITE 5 AC1 20 ASP A 381 PHE A 382 SER A 385 HOH A 649 SITE 1 AC2 20 LEU B 248 ALA B 269 LYS B 271 GLU B 286 SITE 2 AC2 20 MET B 290 ILE B 293 LEU B 298 VAL B 299 SITE 3 AC2 20 ILE B 313 THR B 315 GLU B 316 PHE B 317 SITE 4 AC2 20 MET B 318 HIS B 361 LEU B 370 VAL B 379 SITE 5 AC2 20 ALA B 380 ASP B 381 PHE B 382 HOH B 646 CRYST1 34.020 123.960 139.590 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.029394 0.000000 0.000000 0.00000 SCALE2 0.000000 0.008067 0.000000 0.00000 SCALE3 0.000000 0.000000 0.007164 0.00000